Ignite Creation Date:
2025-12-25 @ 3:57 AM
Ignite Modification Date:
2026-02-22 @ 2:31 PM
Study NCT ID:
NCT01734902
Status:
COMPLETED
Last Update Posted:
2019-04-23
First Post:
2012-11-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female Volunteers
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11-01
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12-01
Completion Date Type:
ACTUAL
First Submit Date:
2012-11-23
First Submit QC Date:
None
Study First Post Date:
2012-11-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-12-20
Results First Submit QC Date:
None
Results First Post Date:
2019-04-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-22
Last Update Post Date:
2019-04-23
Last Update Post Date Type:
ACTUAL